Publications by authors named "Husein Husein-Elahmed"

Article Synopsis
  • Recent developments in understanding AD have highlighted the OX40 receptor's role, leading to new treatments that block the OX40 ligand, which have shown considerable improvement in patients with moderate to severe AD.
  • A thorough review of anti-OX40 treatments suggests they could be a promising option for AD management, but further studies are necessary to evaluate their long-term effectiveness in treating the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Psoriasis is a long-lasting skin condition, and new medicines (biologics) help treat it, but we need to look at how well these medicines work over a longer time, not just at first!
  • This study compared different treatments for psoriasis over 5 years to see how many patients kept improving!
  • The results showed that guselkumab and ixekizumab worked best for helping people maintain clear skin, while other treatments were less effective!*
View Article and Find Full Text PDF
Article Synopsis
  • Hidradenitis suppurativa (HS) is a tough inflammatory skin disorder, and there's been a lot of testing on various biologic treatments, but it’s hard to know which one works best because of a lack of direct comparison studies.
  • A network meta-analysis of 13 studies involving nearly 2,750 participants indicated that adalimumab and secukinumab are among the most effective biologics for treating moderate-to-severe HS, showing significantly better clinical responses compared to placebo.
  • While adalimumab targeting TNF-alpha appears to be the best option, secukinumab blocking IL-17 also shows promise; however, there’s not enough evidence to recommend other pathways like IL-23 for further
View Article and Find Full Text PDF
Article Synopsis
  • * This research conducted a systematic review and network meta-analysis of randomized trials using the Severity of Alopecia Tool (SALT) to evaluate treatment efficacy, finding that baricitinib (4 mg) was the most effective, followed by ritlecitinib (200/50 mg) and ivarmacitinib (4 mg).
  • * The study highlights the potential of JAK inhibitors for hair regrowth and notes that while baricitinib and ritlecitinib showed significant effectiveness
View Article and Find Full Text PDF

Background: Lichen planopilaris (LPP) is a primary chronic lymphocytic cutaneous disorder that selectively destroys the hair follicles, resulting in scarring alopecia. Unfortunately, current available treatments are not fully effective to stop hair loss, and the level of evidence for medical interventions is weak.

Objectives: The present article aimed to determine the efficacy of the different medical interventions in LPP through a network meta-analysis (NMA).

View Article and Find Full Text PDF

Background: Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The effect of probiotic administration on the severity of AD in adults has shown inconsistent results.

Objectives: To determine the effectiveness of probiotic supplementation as a therapeutic tool for adult AD.

View Article and Find Full Text PDF

Despite a large body of research, the effect of probiotic administration on the incidence and severity of atopic dermatitis (AD) shows conflicting results. We aimed to investigate whether probiotic supplementation reduces the incidence and severity of AD. Three databases were systematically searched.

View Article and Find Full Text PDF
Article Synopsis
  • Almost 50% of psoriasis patients also experience nail psoriasis, and there's limited data comparing the effectiveness of biologic treatments for this condition.
  • A systematic review and network meta-analysis were carried out to evaluate how well different biologics help achieve complete resolution of nail psoriasis.
  • The analysis revealed ixekizumab is the most effective treatment for nail psoriasis compared to others like adalimumab, making it a top choice for patients focused on nail symptom clearance.
View Article and Find Full Text PDF

Tofacitinib is a pan-janus kinase inhibitor (JAK) which has been tested off-label in alopecia areata (AA) with promising results. However, evidence of tofacitinib in real-life setting is still poor. We evaluated long-term efficacy and safety of tofacitinib for refractory AA.

View Article and Find Full Text PDF
Article Synopsis
  • Some people with psoriasis might get a skin problem called bullous pemphigoid (BIBP) from medicines called biologics that they take for their psoriasis.
  • Researchers looked at many studies to find out how often this happens and how serious it can be.
  • They found 15 cases of BIBP linked to different biologic medicines, with ustekinumab causing the most instances, and it's really important for doctors to watch their patients’ skin closely when using these treatments.
View Article and Find Full Text PDF

Recent advances in laser technology allowed the development of systems that improve texture, appearance and pliability of skin in acne scars (AS). Currently, comprehensive comparative studies on the efficacy of the most commonly used fractional systems in AS are lacking. Thus, the aim of this work was to appraise and compare the clinical response to erbium versus CO lasers in AS in the form of a meta-analysis.

View Article and Find Full Text PDF

Background: The current scenario and position of laser and light-based therapies (LLBT) in the therapeutic rosacea scheme are lacking evidence-based recommendations and comparisons on efficacy and tolerability among different devices. This article aimed to systematically compare the efficacy, acceptability, and tolerability of the pulsed dye laser (PDL) versus other devices.

Method: A literature search was conducted in March 2020.

View Article and Find Full Text PDF

Introduction: Atopic dermatitis (AD) is a common chronic inflammatory condition. Ustekinumab is a human monoclonal antibody approved for psoriasis, that targets the interleukin (IL)-12 and IL-23, and it may also play a role in AD. Administration of ustekinumab in AD is presented in anecdotal reports with conflicting results.

View Article and Find Full Text PDF

Introduction: Drugs for alopecia areata (AA) can induce hair regrowth, but do not change the disease course. Dual properties of cyclosporine A (CsA) as hypetrichotic and immunosuppressive agent have encouraged use in AA. We aimed to determine the most meaningful efficacy of CsA and reveal features helping enhance its efficacy and reduce relapses.

View Article and Find Full Text PDF

Unlike other rosacea therapies which need daily takings or applications over long periods, the edge of lasers and light-based therapies (LLBT) is the limited number of sessions to achieve improvement. The proper selection of the adequate physical device in accordance with the patients' skin features and rosacea-related signs and symptoms should be considered and the management with physical sources should be updated as new data become available. This article reviews and discusses the current use of lasers and light-based therapies in rosacea with reference to all the available literature.

View Article and Find Full Text PDF
Article Synopsis
  • Dupilumab is a medicine that helps people with a skin condition called prurigo nodularis (PN), but we didn't have clear info on how well it works for this use until now.
  • In a study of 45 patients, most (82%) saw their itching reduced by half, and about half (49%) had no more itching after treatment.
  • It takes a few weeks to start feeling better, especially for people with another skin condition called atopic dermatitis (AD), which may need longer treatment to really help.
View Article and Find Full Text PDF

Background: Low-dose doxycycline (SDD) is an antimicrobial agent that appears to improve common inflammatory skin diseases. Few data are available regarding the overall effectiveness, appropriate length of treatment and optimal patient selection for rosacea. We therefore reviewed the efficacy of sub-antimicrobial doses of SDD in papulopustular rosacea (PPR) and aimed to determine the most suitable patients for this approach.

View Article and Find Full Text PDF

Human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide and ano-genital warts (AGWs) are highly infectious. This virus is transmitted through sexual, anal, or oral contact as well as skin-to-skin contacts. Treatment for this condition has significant morbidity and it can be frustrating in certain cases.

View Article and Find Full Text PDF

Rosacea is a chronic dermatosis which affects negatively patients' quality of life (QoL). There is shortage of high-quality evidence comparing the efficacy of ivermectin cream (IVM) 1% with other available topical choices. Besides, the well-documented impaired of self-esteem and stigmatization of rosacea patients make essential to address which treatment provides the greatest psychological and social benefit.

View Article and Find Full Text PDF

Unlabelled: Vogt-Koyanagi-Harada disease is rare, mediated by autoimmune melanocyte inflammation and facilitated by genetic predisposition. The main clinical features include uveitis, meningitis, tinnitus and sensorineural deafness, and skin and hair depigmentation. It usually develops in four consecutive stages: prodromal, acute uveitic, convalescent, and chronic or recurrent.

View Article and Find Full Text PDF